ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt

It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the mRNA-based therapeutics pioneer behind the world’s most widely-used COVID-19 vaccine. Developed in record time in partnership with Pfizer, thanks to an existing partnership to work on immunization for the common flu, BioNTech’s mRNA inoculation is […]

It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the mRNA-based therapeutics pioneer behind the world’s most widely-used COVID-19 vaccine. Developed in record time in partnership with Pfizer, thanks to an existing partnership to work on immunization for the common flu, BioNTech’s mRNA inoculation is without a doubt one of the biggest medical innovations of the past century.

BioNTech co-founder and CEO Uğur Şahin isn’t stopping there, of course: the company recently announced that it would be developing an mRNA-based vaccine targeting malaria, an illness that still kills more than 400,000 people per year. It also has treatments for a range of cancers in process in its development pipeline, and has announced plans to address HIV and tuberculosis with future candidates.

This year at Disrupt 2021, Şahin will join us along with Mayfield Fund Partner Ursheet Parikh, a key investor in BioNTech. Both Şahin and Parikh will be talking to us about how the COVID-19 vaccine came to be, but more importantly, about what the future holds for mRNA technology and its potential to address a wide range of chronic healthcare problems that have been tough challenges to solve for decades or even centuries. We’ll also be talking about what it means to build a biotech startup with true platform potential, and how that might differ now as compared to what investors were looking for just a few short years ago.

Şahin and Parikh are just two of the many high-profile speakers who will be on our Disrupt Stage and the Extra Crunch Stage. During the three-day event, writer, director, actor and Houseplant co-founder Seth Rogen will be joined by Houseplant Chief Commercial Officer Haneen Davies and co-founder and CEO Michael Mohr to talk about the business of weed, Secretary of Transportation Pete Buttigieg will talk about the future of getting around and the government’s role in partnering with startups, and Coinbase CEO Brian Armstrong will dig into the volatile world of cryptocurrency and his company’s massive direct listing earlier this year.

Disrupt 2021 wouldn’t be complete without Startup Battlefield, the competition that launched some of the world’s biggest tech companies, including Cloudflare and Dropbox. Join Secretary Buttigieg and over 10,000 of the startup world’s most influential people at Disrupt 2021 online this September 21-23. Check out the Disrupt 2021 agenda. We’ll add even more speakers.

Buy your Disrupt pass before July 30 at 11:59 pm (PT), and get ready to join the big, bold and influential — for less than $100.

Get your pass to attend now for under $99 for a limited time!

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.